Glaucoma secondary to eye inflammation

H7_GLAUCSECINFLAM

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H40.4
  • Hospital discharge: ICD-9 3656F|3656B
  • Hospital discharge: ICD-8 36401
  • Cause of death: ICD-10 H40.4
  • Cause of death: ICD-9 3656F|3656B
  • Cause of death: ICD-8 36401

2 out of 7 registries used, show all original rules.

316

4. Check minimum number of events

None

316

5. Include endpoints

None

316

6. Filter based on genotype QC (FinnGen only)

316

Control definitions (FinnGen only)

Control exclude
H7_GLAUCOMA

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF6
Parent code in ICD-10
H40
Name in latin
Glaucoma [secundarium] postinflammatorium

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2511 1296 1195
Only index persons 2084 1092 992
Unadjusted period prevalence (%)
Whole population 0.04 0.04 0.03
Only index persons 0.04 0.04 0.04
Median age at first event (years)
Whole population 50.74 54.42 46.51
Only index persons 47.68 51.18 43.82

-FinnGen-

Key figures

All Female Male
Number of individuals 316 172 144
Unadjusted period prevalence (%) 0.06 0.06 0.06
Median age at first event (years) 48.13 50.02 45.88

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
275
Matched controls
2749
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
+∞
267.3
211
*
S01ED51
ATC
timolol, combinations; ophthalmic
224.0
210.7
200
32
114
Kela drug reimbursment
Glaucoma
185.4
196.6
191
33
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
+∞
159.3
137
*
H20.1
ICD-10 Finland
Chronic iridocyclitis
429.0
158.6
145
7
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
99.7
149.7
159
37
S01ED01
ATC
timolol; ophthalmic
204.4
145.5
141
14
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
715.7
131.9
120
*
S01EC01
ATC
acetazolamide; systemic
133.6
118.5
121
16
S01EE01
ATC
latanoprost; ophthalmic
103.9
106.0
112
18
H40.0
ICD-10 Finland
Glaucoma suspect
293.0
99.8
96
5
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
78.6
75.1
83
15
XCK00
NOMESCO Finland
Perimetry
36.8
75.0
97
40
Z96.1
ICD-10 Finland
Presence of intraocular lens
14.7
67.9
127
151
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
+∞
65.2
60
*
S01EC04
ATC
brinzolamide; ophthalmic
99.7
63.5
68
9
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
24.5
59.3
86
50
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
38.5
58.3
74
26
S01EE03
ATC
bimatoprost; ophthalmic
319.0
53.1
52
*
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
319.0
53.1
52
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
11.3
51.9
109
151
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
7.4
51.8
182
572
S01EA03
ATC
apraclonidine; ophthalmic
130.7
50.8
53
5
S01BC03
ATC
diclofenac; ophthalmic
37.5
50.3
64
22
H26.2
ICD-10 Finland
Complicated cataract
59.5
49.3
57
12
S01EE05
ATC
tafluprost; ophthalmic
41.9
46.0
57
17
XCW99
NOMESCO Finland
Other investigative procedure of eye
11.1
44.9
93
121
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
43.4
43.2
53
15
S01EC03
ATC
dorzolamide; ophthalmic
246.7
42.1
42
*
H40.8
ICD-10 Finland
Other glaucoma
+∞
39.5
37
*
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
+∞
37.3
35
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
10.5
37.3
78
100
S01FA04
ATC
cyclopentolate; ophthalmic
52.1
37.2
44
10
S01EE04
ATC
travoprost; ophthalmic
79.8
37.1
41
6
S01EX03
ATC
NA
206.2
35.7
36
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
5.1
35.4
176
711
Z01.0
ICD-10 Finland
Examination of eyes and vision
6.5
33.9
102
227
CJB10
NOMESCO Finland
Laser discission of secondary cataract
10.9
33.8
68
80
WX140
NOMESCO Finland
Parabulbar anesthesy
17.4
33.7
54
38
36401
ICD-8 Finland
Iritis, Iridocyclitis glaucomatosa. Syndroma Posner-Schlossman, heterochromia iridis
+∞
33.0
31
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
10.0
32.9
70
91
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
5.0
32.8
141
475
H40.9
ICD-10 Finland
Glaucoma, unspecified
364.0
32.6
32
*
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
27.3
32.1
44
19
3641A
ICD-9 Finland
Disorders of iris and ciliary body, Chronic iridocyclitis
+∞
31.9
30
*
XCK10
NOMESCO Finland
Photography of fundus of eye
8.0
30.5
75
123
H26.4
ICD-10 Finland
After-cataract
9.0
30.5
69
99
XCH00
NOMESCO Finland
Eye pressure measurement
17.9
30.5
48
32
3656F
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA POST UVEITIDEM]
+∞
29.7
28
*
3656B
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUKOMASYKLIITTINEN KRIISI,SYNDR POSSNER-SCHOSSMAN]
+∞
28.6
27
*
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
14.8
25.4
43
34
CHC05
NOMESCO Finland
Iridotomy
+∞
25.4
24
*
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
273.9
25.1
25
*
S01ED02
ATC
betaxolol; ophthalmic
74.5
24.3
27
*
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
74.5
24.3
27
*
S01FA01
ATC
atropine; ophthalmic
136.9
24.0
25
*
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
18.6
23.5
36
22
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
+∞
23.3
22
*
S01EB01
ATC
pilocarpine; ophthalmic
+∞
23.3
22
*
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
25.7
23.2
32
14
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
238.2
21.9
22
*
L04AB04
ATC
adalimumab; parenteral
21.6
21.4
31
16
S01FA02
ATC
scopolamine; ophthalmic
28.1
20.9
28
11
CHD99
NOMESCO Finland
Other filtering operation
+∞
20.0
19
*
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
+∞
20.0
19
*
CHD15
NOMESCO Finland
Trabeculectomy and iridectomy
+∞
20.0
19
*
S01EC54
ATC
brinzolamide, combinations; ophthalmic
113.3
19.8
21
*
36402
ICD-8 Finland
Iritis, Iridocyclitis, uveitis chronica
203.3
18.8
19
*
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
15.2
18.2
30
22
3663A
ICD-9 Finland
Cataract secondary to ocular disorders
56.6
18.2
21
*
H30.2
ICD-10 Finland
Posterior cyclitis
+∞
17.9
17
*
ZXA00
NOMESCO Finland
Right side
3.4
17.9
113
471
H20.8
ICD-10 Finland
Other iridocyclitis
101.7
17.8
19
*
H02AB06
ATC
prednisolone; systemic
3.0
17.1
166
925
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
8.3
16.9
38
52
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
43.0
16.6
20
5
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
50.8
16.2
19
*
36400
ICD-8 Finland
Iritis, Iridocyclitis acuta
63.9
16.0
18
*
H26.3
ICD-10 Finland
Drug-induced cataract
23.8
15.8
22
10
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
6.8
15.2
39
65
S01EA02
ATC
dipivefrine; ophthalmic
+∞
14.7
14
*
37520
ICD-8 Finland
Glaucoma, Secondary
+∞
14.7
14
*
ZXC20
NOMESCO Finland
Use of chemical agents
13.6
14.7
25
20
WX100
NOMESCO Finland
Conjunctival surface anesthesia
4.5
13.7
51
132
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
79.2
13.7
15
*
XCH05
NOMESCO Finland
Eye pressure longterm registration
79.2
13.7
15
*
H26.02
ICD-10 Finland
Presenil cataract
14.8
13.5
22
16
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
42.3
13.3
16
*
S01BC05
ATC
ketorolac; ophthalmic
7.2
13.3
32
49
L88
ICPC
Rheumatoid/seropositive arthritis
8.0
12.9
29
40
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
25.8
12.6
17
7
H21.1
ICD-10 Finland
Other vascular disorders of iris and ciliary body
+∞
12.6
12
*
3656X
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA SECUNDARIA ALIA SEU NUD]
+∞
12.6
12
*
ZXA05
NOMESCO Finland
Left side
2.8
12.5
97
442
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
6.6
12.4
32
54
H16.0
ICD-10 Finland
Corneal ulcer
7.0
12.3
30
47
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
19.1
12.2
18
10
S01FA06
ATC
tropicamide; ophthalmic
48.9
12.0
14
*
L04AA01
ATC
[U] ciclosporin; systemic
20.0
11.7
17
9
H40.20
ICD-10 Finland
Acute glaucoma with closed ventricular angle
+∞
11.5
11
*
3708
FHL
Trabeculectomy or equivalent
+∞
11.5
11
*
H18.1
ICD-10 Finland
Bullous keratopathy
+∞
11.5
11
*
Z94.7
ICD-10 Finland
Corneal transplant status
125.0
11.5
12
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
5.3
11.5
35
73
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
21.1
11.3
16
8
3640A
ICD-9 Finland
Disorders of iris and ciliary body, Acute and subacute iridocyclitis
62.5
10.7
12
*
A07EC01
ATC
sulfasalazine; oral, rectal
4.2
10.5
41
111
H40.6
ICD-10 Finland
Glaucoma secondary to drugs
+∞
10.5
10
*
37403
ICD-8 Finland
Cataract, Complicata
+∞
10.5
10
*
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
34.0
10.4
13
*
3626
FHL
Extracapsular cataract surgery and implantation of an artificial lens
9.0
10.3
21
25
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
7.0
10.0
24
37
M45
ICD-10 Finland
Ankylosing spondylitis
9.3
10.0
20
23
L04AX01
ATC
azathioprine; systemic
6.1
9.8
26
46
TCG10
NOMESCO Finland
Removal of sutures from cornea
57.1
9.7
11
*
H25.1
ICD-10 Finland
Senile nuclear cataract
2.6
9.5
84
404
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
+∞
9.4
9
*
CHD35
NOMESCO Finland
Laser goniopuncture
+∞
9.4
9
*
H221, M084
ICD-10 Finland
NA
+∞
9.4
9
*
CFW99
NOMESCO Finland
Other operation on conjunctiva
+∞
9.4
9
*
3793A
ICD-9 Finland
Other disorders of eye, Aphakia and other disorders of lens[APHAKIA]
+∞
9.4
9
*
CHD00
NOMESCO Finland
Laser trabeculoplasty
38.0
9.1
11
*
CA1ME
NOMESCO Finland
Ultrasound oculometry
28.5
8.5
11
*
H33.0
ICD-10 Finland
Retinal detachment with retinal break
8.3
8.5
18
23
H15.1
ICD-10 Finland
Episcleritis
13.3
8.5
14
11
H21.0
ICD-10 Finland
Hyphaema
92.8
8.5
9
*
H40.11
ICD-10 Finland
Low pressure glaucoma
92.8
8.5
9
*
H22.1*D86.8
ICD-10 Finland
Iridocyclitis in sarcoidosis
92.8
8.5
9
*
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
+∞
8.4
8
*
H221, M083
ICD-10 Finland
NA
+∞
8.4
8
*
WX142
NOMESCO Finland
Sub-tenon anesthesy
+∞
8.4
8
*
H40.3
ICD-10 Finland
Glaucoma secondary to eye trauma
+∞
8.4
8
*
H44.4
ICD-10 Finland
Hypotony of eye
+∞
8.4
8
*
Z3229
NOMESCO Finland
Other healthcare associate professional
3.5
8.3
39
124
S01AX11
ATC
[U] ofloxacin; ophthalmic
6.2
8.2
21
36
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.3
8.1
29
73
H11.3
ICD-10 Finland
Conjunctival haemorrhage
5.7
7.7
21
39
ZXA10
NOMESCO Finland
Bilateral
2.5
7.6
64
296
L04AA13
ATC
leflunomide; oral
8.0
7.5
16
21
71200
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis
82.2
7.5
8
*
37872
ICD-8 Finland
Other diseases of eye, Aphakia artefacta, acquisita
82.2
7.5
8
*
CGG45
NOMESCO Finland
Full thickness transplantation of cornea using homograft
+∞
7.3
7
*
H40.19
ICD-10 Finland
Other primary glaucoma with open ventricular angle
+∞
7.3
7
*
H40.22
ICD-10 Finland
Chronic glaucoma with closed ventricular angle
+∞
7.3
7
*
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
+∞
7.3
7
*
TCF00
NOMESCO Finland
Subconjunctival therapeutic injection
30.9
7.2
9
*
L04AA17
ATC
[U] adalimumab; parenteral
30.9
7.2
9
*
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
4.2
7.1
26
67
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
7.0
105
634
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
7.0
6.9
16
24
H04.10
ICD-10 Finland
Dry eye syndrome
3.1
6.8
36
126
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
17.2
6.8
10
6
H40
ICD-10 Finland
Glaucoma
41.1
6.8
8
*
L04AB06
ATC
golimumab; parenteral
23.2
6.7
9
*
S01AD03
ATC
aciclovir; ophthalmic
4.4
6.7
23
56
H02AB07
ATC
prednisone; oral
2.6
6.5
50
220
CHB10
NOMESCO Finland
Puncture of anterior chamber of eye with irrigation
71.4
6.5
7
*
S01BC01
ATC
indometacin; ophthalmic
71.4
6.5
7
*
CS2P4
NOMESCO Finland
Optic nerve head imaging
71.4
6.5
7
*
CFD10
NOMESCO Finland
Repair of conjunctiva
71.4
6.5
7
*
S01FB01
ATC
phenylephrine; ophthalmic (sympathomimetics excl. antiglaucoma prep.)
71.4
6.5
7
*
H27.0
ICD-10 Finland
Aphakia
71.4
6.5
7
*
Z3231
NOMESCO Finland
Registered nurse
2.1
6.4
87
501
L04AD01
ATC
ciclosporin; systemic
8.5
6.4
13
16
CHB99
NOMESCO Finland
Other operation on anterior chamber and anterior chamber angle
+∞
6.3
6
*
7143D
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[OLIGARTHRITIS JUVENILIS]
+∞
6.3
6
*
37510
ICD-8 Finland
Glaucoma, Chronicum simplex
+∞
6.3
6
*
3719
FHL
Other measure in this category
+∞
6.3
6
*
CGG99
NOMESCO Finland
Other reconstructive operations on cornea and sclera
+∞
6.3
6
*
TCH12
NOMESCO Finland
Sample aspiration from anterior chambre
+∞
6.3
6
*
M08.9
ICD-10 Finland
Juvenile arthritis, unspecified
+∞
6.3
6
*
CGG31
NOMESCO Finland
Posterior corneal lamellar transplantation
+∞
6.3
6
*
H18.8
ICD-10 Finland
Other specified disorders of cornea
27.4
6.3
8
*
L04AB05
ATC
certolizumab pegol; parenteral
27.4
6.3
8
*
P01BA02
ATC
hydroxychloroquine; oral
3.3
6.1
29
94
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.8
6.1
24
67

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
149
797
2.65
15.93
9.7
5.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
192
1210
2.50
13.88
10.4
5.7
e9/l
0.0
0.0
0.25
176
1056
(3019198) Lymphocytes [#/volume] in Blood
193
1239
2.43
13.10
10.7
5.7
e9/l
1.9
1.9
0.19
177
1107
(3001604) Monocytes [#/volume] in Blood
189
1204
2.42
13.02
10.6
5.6
e9/l
0.6
0.6
0.62
175
1047
(3019069) Monocytes/100 leukocytes in Blood
181
1135
2.39
12.88
11.6
6.1
%
8.8
8.6
0.55
173
1067
(3013115) Eosinophils [#/volume] in Blood
193
1245
2.41
12.87
10.5
5.9
e9/l
0.2
0.2
0.06
178
1107
(3006504) Eosinophils/100 leukocytes in Blood
180
1128
2.38
12.80
11.2
5.8
%
2.7
2.8
0.55
172
1051
(3013650) Neutrophils [#/volume] in Blood by Automated count
209
1406
2.44
12.53
11.2
9.4
e9/l
4.0
4.1
0.18
191
1230
(3022096) Basophils/100 leukocytes in Blood
176
1102
2.35
12.41
11.1
5.8
%
0.7
0.7
0.43
170
1028
(3018010) Neutrophils/100 leukocytes in Blood
181
1154
2.33
12.14
11.0
5.7
%
57.9
57.6
0.11
175
1085
(3002030) Lymphocytes/100 leukocytes in Blood
181
1165
2.30
11.72
11.5
5.9
%
27.2
27.6
0.22
174
1086
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
29
75
4.16
10.37
1.8
1.5
iu/ml
1.3
0.1
—
8
17
(3025159) Blasts/100 leukocytes in Blood
47
169
3.09
10.28
5.8
5.6
%
0.0
0.2
—
9
51
(3021440) Promyelocytes/100 leukocytes in Blood
48
178
3.00
9.95
6.0
5.4
%
0.1
0.1
0.13
11
56
(3035350) Ketones [Presence] in Urine by Test strip
173
1172
2.05
8.93
4.2
3.6
estimate
0.0
0.0
0.00
32
228
(3017181) Myelocytes/100 leukocytes in Blood
49
195
2.79
8.91
6.1
5.2
%
1.4
1.0
0.25
11
64
(3002179) Metamyelocytes/100 leukocytes in Blood
45
172
2.88
8.82
5.3
5.3
%
1.4
0.4
—
8
43
(3021601) Nitrite [Presence] in Urine by Test strip
171
1174
1.99
8.29
5.9
5.0
estimate
0.0
0.0
0.00
35
228
(3009261) Glucose [Presence] in Urine by Test strip
171
1187
1.96
7.89
4.2
3.7
estimate
0.1
0.0
0.49
31
219
(3008898) HLA-B27 [Presence]
28
90
3.32
7.33
1.2
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
60
294
2.28
7.01
1.4
1.4
titre
752.7
479.4
0.50
22
70
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
36
4.63
6.78
4.6
3.5
%
61.0
60.0
0.08
16
36
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
36
4.63
6.78
4.0
2.6
e9/l
4.7
5.0
0.14
16
36
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
28
5.19
6.77
1.3
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
14
7.34
6.73
1.0
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
97
594
1.91
6.20
8.2
7.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
27
4.98
6.03
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
27
4.98
6.03
1.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
88
528
1.92
5.95
7.6
4.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
224
1788
1.87
5.91
7.1
3.9
mm/h
12.3
12.0
0.14
218
1627
(3021589) Normoblasts [#/volume] in Blood
151
1076
1.77
5.82
14.8
9.4
e9/l
0.0
0.0
0.42
132
886
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
155
1140
1.71
5.14
6.5
7.4
mmol/l
1.2
1.2
0.36
128
971
(3011397) Hemoglobin [Presence] in Urine by Test strip
84
521
1.83
5.04
4.1
3.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
130
928
1.68
4.71
4.4
3.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
207
1671
1.69
4.64
5.5
4.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
11
8.38
4.59
1.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
11
29
3.89
3.83
1.7
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
34
3.63
3.80
1.0
7.8
—
304.7
—
0
7
(3041096) Erythrocytes [Presence] in Urine by Automated
97
676
1.63
3.70
3.6
3.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
221
1866
1.61
3.68
9.3
7.2
u/l
76.6
77.8
0.12
213
1734
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
138
1050
1.56
3.61
5.3
6.5
mmol/l
1.2
1.2
0.37
128
937
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
127
949
1.57
3.60
2.5
2.2
nmol/l
78.4
76.5
0.36
117
841
(3004789) Transferrin [Mass/volume] in Serum or Plasma
55
333
1.79
3.50
1.9
2.1
g/l
2.3
2.4
0.12
49
305
(3018418) pH of Serum or Plasma
96
676
1.60
3.49
3.9
3.8
ph
7.4
7.4
0.55
20
108
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
54
2.87
3.30
1.3
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
45
266
1.81
3.10
1.6
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
8
7.62
3.06
1.0
1.0
miu/ml
1245.8
1401.0
—
6
8
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
13
45
2.97
3.06
1.1
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
5
10.13
2.99
2.2
1.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
6
9
6.77
2.88
5.0
5.6
%
55.5
49.4
—
6
9
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
47
2.84
2.85
1.1
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
18
4.53
2.81
1.4
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
6
8.44
2.76
1.6
3.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
76
533
1.56
2.75
4.3
3.9
kg/l
1.0
1.0
—
10
72
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
270
2455
1.69
2.74
18.8
14.2
mg/l
21.2
23.3
0.45
223
1939
(3042936) Bacteria identified in Isolate by Culture
52
333
1.67
2.72
2.2
2.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
47
294
1.70
2.68
1.2
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
40
240
1.76
2.63
3.2
3.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
32
179
1.88
2.63
3.0
2.6
ml/min/173m2
73.6
63.9
—
10
72
(40767503) Oxygen content in Capillary blood by calculation
11
38
2.96
2.61
1.5
2.6
%
17.1
16.2
—
5
22
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
110
852
1.45
2.44
3.2
3.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
28
154
1.90
2.43
2.8
2.4
—
26.9
—
0
7
(3045414) Leukocytes [Presence] in Urine
20
97
2.13
2.43
2.3
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
17
4.19
2.37
2.0
1.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
104
804
1.44
2.31
3.4
3.1
u/l
49.1
30.9
0.41
99
773
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
118
935
1.42
2.29
2.1
1.9
pmol/l
89.3
96.0
1.00
68
477
(3018095) Leukocytes [#/volume] in Urine
110
862
1.42
2.26
4.0
3.5
e6/l
59.8
71.4
0.12
75
617
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
48
316
1.61
2.26
2.0
2.1
%
21.6
22.2
0.10
40
270
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
5
9
5.62
2.22
1.0
1.1
%
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
87
656
1.45
2.20
4.5
3.9
estimate
0.0
0.0
0.50
34
224
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
24
3.39
2.19
1.1
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
23
123
1.94
2.18
4.5
3.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
33
200
1.73
2.12
4.0
3.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
117
937
1.39
2.10
10.4
8.9
inr
1.2
1.2
0.07
43
271
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
279
2598
1.63
2.09
15.8
9.9
u/l
26.6
26.2
0.06
273
2495
(3017732) Neutrophils [#/volume] in Blood
28
164
1.78
2.02
3.9
2.7
e9/l
3.8
3.9
0.03
22
129
(3000850) Epithelial cells [#/volume] in Urine
69
505
1.47
2.02
2.3
2.4
e6/l
4.1
5.0
0.45
60
443
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
39
251
1.63
2.02
2.2
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
66
481
1.47
1.97
2.8
2.7
mosm/kgh2o
502.1
560.3
1.15
54
415
(3022806) Fractional oxyhemoglobin in Capillary blood
7
21
3.38
1.97
1.0
1.9
%
91.2
89.8
—
7
21
(3024561) Albumin [Mass/volume] in Serum or Plasma
124
1012
1.37
1.96
4.1
4.7
g/l
35.4
35.6
0.10
114
949
(3004588) Protein electrophoresis panel - Serum or Plasma
26
152
1.77
1.90
2.8
2.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
62
451
1.47
1.87
1.8
1.6
nmol/l
1340.2
1204.5
0.50
50
340
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
17
3.58
1.84
1.5
2.5
%
13.3
13.2
—
6
17
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
12
4.21
1.83
1.8
2.3
u/ml
662.2
983.4
—
5
12
(3044889) 12 lead EKG panel
189
1659
1.35
1.81
3.8
3.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
70
525
1.43
1.80
2.0
1.8
mg/l
1.2
1.3
0.22
58
405
(3021879) Hepatitis B virus core Ab [Presence] in Serum
30
186
1.68
1.80
1.2
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
90
707
1.38
1.78
3.4
3.2
ng/l
2171.8
1451.1
0.52
80
592
(1616796) Gas panel - Central venous blood
10
41
2.49
1.77
2.0
2.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
18
3.38
1.75
1.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
18
3.38
1.75
1.3
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
24
2.96
1.73
1.1
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
48
2.34
1.72
1.5
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
53
382
1.47
1.68
1.2
1.6
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
7
25
2.84
1.66
1.3
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
206
1845
1.33
1.65
4.4
3.7
pmol/l
15.1
14.7
1.95
193
1650
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
5
14
3.61
1.62
1.2
1.0
u/l
43.6
44.1
—
5
8
(3034770) Mitochondria Ab [Titer] in Serum
12
57
2.15
1.57
1.0
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
81
639
1.36
1.55
3.1
2.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
53
389
1.44
1.54
1.2
1.3
iu/ml
88.0
48.3
0.34
15
126
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
27
2.63
1.52
2.3
2.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
21
2.89
1.51
1.0
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
123
1038
1.30
1.47
2.7
2.5
ug/l
112.6
120.5
0.20
118
947
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
37
255
1.51
1.47
2.2
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
73
1.96
1.46
1.6
2.9
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
9
39
2.35
1.44
1.7
2.7
kpa
8.6
8.3
—
9
39
(3013290) Carbon dioxide [Partial pressure] in Blood
9
39
2.35
1.44
1.7
2.7
kpa
4.9
4.9
—
9
39
(3026493) Urate [Moles/volume] in Serum or Plasma
76
601
1.35
1.42
3.0
2.7
umol/l
11710.0
5377.7
0.35
60
512
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
75
592
1.35
1.42
2.6
2.0
mg/l
3.1
3.0
0.05
65
502
(3000475) Leukocytes [#/volume] in Synovial fluid
10
46
2.21
1.41
1.8
1.5
e6/l
9954.5
10739.9
—
10
28
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
60
2.04
1.40
1.8
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
14
245
0.55
1.38
1.2
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
50
371
1.41
1.37
3.4
2.8
e6/l
1.3
1.8
0.31
28
208
(4027681)
5
17
2.97
1.36
1.4
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
88
716
1.32
1.36
4.2
3.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
82
663
1.32
1.32
3.4
2.9
e6/l
0.1
0.3
4.08
60
498
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
65
508
1.35
1.31
1.8
1.7
pmol/l
390.7
440.9
1.32
53
438
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
33
228
1.50
1.31
1.8
2.4
u/l
49.1
30.0
1.04
28
193
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
49
366
1.40
1.30
1.2
1.2
u/ml
67.1
13.6
1.10
18
143
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
52
393
1.39
1.29
3.1
2.6
e6/l
0.8
1.0
0.56
30
227
(3014051) Protein [Presence] in Urine by Test strip
10
48
2.12
1.29
3.4
2.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
55
2.04
1.29
1.1
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
49
367
1.40
1.28
2.1
2.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
286
2733
1.49
1.27
27.6
20.4
e9/l
253.9
249.2
0.50
279
2671
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
13
70
1.89
1.26
2.6
1.4
g/l
0.2
0.2
0.20
13
70
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
56
431
1.36
1.25
5.3
4.0
ng/l
206.0
132.4
0.28
46
338
(3044941) Cell count panel - Synovial fluid
6
25
2.43
1.25
2.2
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
25
2.43
1.25
1.3
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
286
2736
1.48
1.23
27.5
20.4
e12/l
4.5
4.5
0.56
277
2663
(3010813) Leukocytes [#/volume] in Blood
286
2736
1.48
1.23
27.5
20.5
e9/l
6.9
6.7
0.66
278
2663
(3021960) Folate [Moles/volume] in Serum or Plasma
69
550
1.33
1.23
1.6
1.5
nmol/l
21.6
20.8
0.15
58
463
(3003396) Base excess in Arterial blood by calculation
38
275
1.43
1.21
6.0
9.8
mmol/l
0.9
1.3
0.24
28
220
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
126
1.63
1.17
2.7
1.9
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
33
0.00
1.17
0.0
2.5
—
3.4
—
0
33
(46235355) HIV 1 and 2 tests - Meaningful Use set
59
465
1.33
1.14
1.5
1.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
88
733
1.28
1.13
3.6
3.0
e6/l
367.1
132.3
0.36
69
569
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
171
1538
1.24
1.13
3.3
3.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
73
1.81
1.12
1.7
1.9
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
21
136
1.58
1.11
4.3
8.5
mmol/l
23.9
24.9
1.16
21
136
(40768443) Skin Pathology biopsy report
17
105
1.65
1.08
1.4
1.2
—
—
—
0
0
(3010421) pH of Blood
9
47
1.94
1.03
1.7
2.6
ph
7.4
7.4
—
9
39
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
38
284
1.38
1.03
2.1
2.5
umol/l
8.2
7.4
0.15
32
249
(40761535) Cells panel - Urine sediment
28
198
1.45
1.02
4.2
3.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
233
1.42
1.00
1.4
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
13
76
1.74
1.00
2.6
1.5
g/l
1.2
1.1
0.55
13
76
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
23
2.19
0.98
1.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
36
1.97
0.97
1.0
1.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
158
1425
1.22
0.97
4.7
5.2
mmol/l
6.9
6.7
0.45
152
1326
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
242
2282
1.26
0.95
17.4
12.9
ml/min/173m2
84.7
81.5
1.35
205
1851
(3025130) Human papilloma virus identified in Specimen
0
32
0.00
0.95
0.0
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
56
450
1.30
0.95
1.4
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
39
297
1.36
0.95
1.3
1.4
—
—
—
0
0
(4062490)
6
27
2.25
0.94
1.3
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
13
78
1.70
0.93
5.2
4.9
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
28
2.16
0.92
1.3
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
237
2235
1.24
0.90
5.1
4.4
mu/l
2.0
1.9
0.16
216
2022
(40761511) CBC panel - Blood by Automated count
268
2564
1.30
0.90
17.2
13.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
29
2.09
0.90
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
42
1.93
0.89
1.3
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
37
288
1.32
0.80
6.4
8.0
mmol/l
104.4
104.1
0.14
37
280
(3020682) Albumin/Creatinine [Ratio] in Urine
82
706
1.22
0.78
4.0
3.8
mg/mmol
7.5
9.6
0.36
52
439
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
142
1290
1.18
0.76
5.7
6.1
umol/l
11.7
11.3
0.13
137
1217
(3012441) Differential panel - Pleural fluid
5
24
2.10
0.75
1.6
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
55
1.65
0.74
1.9
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
25
2.02
0.73
2.4
4.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
25
2.02
0.73
1.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
76
1.60
0.72
1.7
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
57
1.60
0.71
1.2
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
23
170
1.38
0.70
3.0
2.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
22
162
1.38
0.68
1.7
7.6
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
20
145
1.40
0.67
9.1
10.0
%
94.6
94.6
0.01
20
145
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
18
128
1.43
0.67
7.3
14.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
43
1.64
0.67
1.1
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
43
1.64
0.67
1.1
1.3
—
—
—
0
0
(4268621)
5
28
1.80
0.66
2.2
2.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
29
1.74
0.64
2.8
3.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
29
1.74
0.64
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
49
1.65
0.62
1.0
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
72
628
1.19
0.61
1.7
1.7
mmol/l
1.4
1.4
0.29
60
530
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
83
735
1.18
0.59
2.8
2.9
mmol/l
6.8
7.6
0.75
66
616
(3012516) Albumin [Mass/volume] in Urine
76
668
1.18
0.59
2.9
3.1
mg/l
40.5
252.8
0.92
45
423
(3019230) Fractional oxyhemoglobin in Venous blood
6
35
1.73
0.58
1.5
5.7
%
76.6
61.2
—
6
35
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
105
949
1.16
0.58
3.9
3.9
ng/l
21.5
40.0
2.37
67
642
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
36
1.68
0.57
3.0
2.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
26
204
1.30
0.56
3.5
1.9
nmol/l
312.9
363.4
0.77
26
188
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
14
99
1.43
0.55
1.7
2.1
ug/l
0.2
5.0
0.98
14
87
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
24
303
0.77
0.54
3.8
4.5
%
35.4
31.8
0.72
17
202
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
91
1.45
0.54
4.1
2.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
6
39
1.55
0.53
4.2
3.2
nmol/l
0.8
0.9
—
6
30
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
212
0.74
0.50
1.3
1.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
85
764
1.15
0.50
2.2
2.5
u/l
60.4
56.2
0.57
76
702
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
18
136
1.34
0.50
1.7
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
143
0.69
0.49
1.2
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
47
1.50
0.48
2.9
2.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
119
0.66
0.46
1.1
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
7
50
1.41
0.45
1.3
1.3
—
46.6
—
0
6
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
31
1.62
0.43
1.0
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
32
1.57
0.42
1.0
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(4024509)
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
34
1.48
0.40
1.2
1.6
pg
31.8
33.1
—
5
34
(1617658) Protocol used for examination of sentinel lymph nodes
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
10
71
1.42
0.39
1.1
1.4
ug/g
325.4
308.3
—
5
39
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
18
142
1.28
0.39
1.1
1.2
iu/ml
18.9
142.5
—
7
57
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
19
0.00
0.39
0.0
1.1
—
39.0
—
0
10
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.0
—
502.9
—
0
10
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.0
—
262.5
—
0
10
(3007164) IgA [Mass/volume] in Serum or Plasma
54
479
1.15
0.39
1.8
1.4
g/l
2.5
2.4
0.06
35
283
(1002224) Polysomnography panel
12
89
1.36
0.38
1.0
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
72
653
1.13
0.38
4.5
4.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
111
0.71
0.38
1.1
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
22
266
0.81
0.37
2.5
4.4
ug/l
2.6
9.0
2.52
14
221
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
10
134
0.74
0.35
3.6
3.0
u/ml
19.4
36.9
—
10
129
(3000991) Gas panel - Venous blood
23
191
1.22
0.34
8.2
8.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
17
136
1.26
0.34
1.2
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
230
2232
1.11
0.34
20.5
15.0
%
39.0
40.1
0.92
158
1632
(40768800) Prostate Pathology biopsy report
6
46
1.31
0.33
1.5
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
46
1.31
0.33
4.5
5.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
26
220
1.20
0.33
3.4
4.3
kpa
6.0
5.7
0.79
26
212
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
47
1.28
0.32
1.0
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
243
2368
1.11
0.32
4.4
4.4
mmol/l
5.8
5.9
1.01
226
2174
(3019832) Treponema pallidum Ab [Presence] in Serum
28
240
1.18
0.31
1.5
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
100
0.69
0.31
1.7
2.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
102
958
1.10
0.29
2.1
2.1
—
—
—
0
0
(3000492) Spirometry study
19
226
0.83
0.28
1.4
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
84
783
1.10
0.28
2.8
3.5
mmol/l
2.4
2.4
0.20
74
678
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
63
1.28
0.28
1.0
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
38
425
0.88
0.27
3.3
2.9
mmol/l
2.5
2.4
0.08
33
377
(3013512) EKG study
76
706
1.10
0.27
4.7
3.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
67
1.20
0.26
1.5
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
10
77
1.31
0.26
3.4
3.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
10
77
1.31
0.26
3.2
2.3
%
81.9
89.4
—
10
72
(3023520) Reticulocytes [#/volume] in Blood
23
198
1.17
0.25
1.7
2.7
e9/l
68.9
71.0
0.17
18
161
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
26
297
0.86
0.25
1.5
2.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
75
1.21
0.25
1.8
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
62
668
0.91
0.24
1.3
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
115
1.23
0.24
2.9
2.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
92
869
1.08
0.23
3.0
2.7
—
—
—
0
0
(3002256) Pathology report gross observation
33
295
1.13
0.23
1.1
1.2
—
—
—
0
0
(4035726)
19
221
0.85
0.23
1.1
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
229
2239
1.08
0.23
6.6
5.5
mmol/mol
40.9
39.9
0.75
217
2091
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
91
0.76
0.23
3.3
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
7
93
0.75
0.22
1.4
1.5
iu/l
46.6
23.3
—
7
81
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
56
518
1.10
0.22
1.4
1.2
u/ml
0.8
1.5
0.94
15
137
(3043409) Potassium [Moles/volume] in Arterial blood
10
79
1.27
0.22
1.6
3.6
mmol/l
3.9
3.9
—
10
72
(40768797) Stomach Pathology biopsy report
33
296
1.13
0.22
1.2
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
27.6
—
0
11
(3037556) Urate [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012544) pH of Venous blood
26
230
1.14
0.21
3.4
4.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
292
0.88
0.21
9.0
7.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.9
—
11.3
—
0
14
(3028626) Oxygen [Partial pressure] in Capillary blood
8
68
1.18
0.16
2.6
2.5
kpa
8.3
8.2
—
8
62
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
71
1.13
0.16
1.4
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
83
1.21
0.15
1.2
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
34
368
0.91
0.15
1.4
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
242
2385
1.06
0.15
4.2
4.2
mmol/l
1.5
1.5
0.40
225
2207
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
248
2447
1.06
0.14
4.8
4.7
mmol/l
2.6
2.8
1.26
233
2258
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
17
151
1.13
0.13
1.4
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
123
1.14
0.12
1.1
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
25
272
0.91
0.12
1.3
2.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
162
1.12
0.12
2.1
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
75
721
1.05
0.12
2.2
2.1
u/l
138.0
231.6
1.78
69
685
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
80
771
1.05
0.11
5.7
4.8
ug/l
4.1
2.6
0.55
71
681
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
14
124
1.14
0.11
1.4
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
64
614
1.05
0.11
5.2
4.2
%
19.6
21.4
0.48
40
294
(3048689) Calprotectin [Mass/mass] in Stool
28
300
0.93
0.10
1.9
2.2
ug/g
96.9
140.4
0.81
22
238
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
162
1648
0.97
0.09
3.2
2.9
u/l
54.2
46.9
0.38
154
1549
(3019225) pH of Specimen
24
223
1.08
0.09
4.3
4.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
48
1.04
0.09
1.6
6.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
48
1.04
0.09
2.4
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
73
753
0.96
0.08
2.3
2.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
61
0.82
0.08
1.4
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
62
0.80
0.08
1.2
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
62
0.80
0.08
1.4
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
65
0.77
0.08
2.0
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
65
0.77
0.08
1.4
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
18
194
0.92
0.07
1.2
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
7
80
0.87
0.07
1.6
1.4
mu/l
298.7
280.0
—
7
72
(4034850)
9
87
1.04
0.07
6.0
10.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
92
0.87
0.07
1.4
1.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
95
0.84
0.06
1.5
2.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
43
445
0.96
0.05
3.5
3.0
ug/l
0.7
0.8
0.59
33
284
(3022145) Colonoscopy Study observation
29
277
1.05
0.05
1.2
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
20
189
1.06
0.05
4.0
3.8
kpa
4.5
4.3
0.19
20
181
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
12
111
1.08
0.04
1.9
4.9
mmol/l
23.3
24.1
0.56
12
99
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
241
2398
1.02
0.03
4.4
4.3
mmol/l
4.6
4.6
0.39
227
2232
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
55
561
0.98
0.03
2.1
2.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
12
128
0.94
0.02
4.3
3.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
138
0.94
0.02
1.2
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
230
2309
0.99
0.01
3.9
3.8
mmol/l
1.3
1.3
0.02
216
2125
(4010399)
17
163
1.05
0.01
1.5
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
18
173
1.04
0.01
3.9
3.5
kpa
5.2
5.1
0.18
18
160
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
113
1129
1.00
0.00
4.2
4.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
24
236
1.02
0.00
1.3
1.7
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.2
—
1.3
—
0
6
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
7
0.00
0.00
0.0
1.7
—
135.3
—
0
7
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
75
0.93
0.00
1.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
12.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
75
0.93
0.00
1.7
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
53
0.94
0.00
1.2
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
92
0.98
0.00
1.7
1.4
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
85
0.94
0.00
1.6
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
6
64
0.94
0.00
5.7
4.2
—
3.0
—
0
9
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
82
0.97
0.00
1.1
1.3
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
0.3
—
0
9
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
56
0.89
0.00
1.2
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
59
0.85
0.00
1.0
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
18.1
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
1.0
—
4.8
—
0
5
(3027008) Opiates [Presence] in Urine
9
92
0.98
0.00
1.6
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
53
0.94
0.00
1.2
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020891) Body temperature
9
91
0.99
0.00
1.8
4.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
1.1
—
0
5
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
8
79
1.01
0.00
1.4
1.6
—
116.0
—
0
5
(3015235) Bicarbonate [Moles/volume] in Capillary blood
6
68
0.88
0.00
3.8
2.1
mmol/l
25.6
24.9
—
6
55
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
13.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
92
0.98
0.00
1.6
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
13.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
92
0.98
0.00
1.6
1.4
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint H7_GLAUCSECINFLAM and mortality.

Females

Parameter HR [95% CI] p-value
H7_GLAUCSECINFLAM 1.399 [1.15, 1.7] < 0.001
Birth year 0.993 [0.98, 1.0] 0.129

During the follow-up period (1.1.1998 — 31.12.2019), 148 out of 753 females with H7_GLAUCSECINFLAM died.

Males

Parameter HR [95% CI] p-value
H7_GLAUCSECINFLAM 1.0 [0.79, 1.26] 0.997
Birth year 0.987 [0.98, 1.0] 0.007

During the follow-up period (1.1.1998 — 31.12.2019), 114 out of 629 males with H7_GLAUCSECINFLAM died.

Mortality risk

Mortality risk for people of age

years, who have H7_GLAUCSECINFLAM.

N-year risk Females Males
1 0.159% 0.192%
5 0.754% 1.124%
10 1.798% 2.812%
15 3.606% 5.501%
20 6.519% 9.447%

Relationships between endpoints

Index endpoint: H7_GLAUCSECINFLAM – Glaucoma secondary to eye inflammation

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data